Carcinoembryonic antigen (CEA) was first described by Gold and Freeman (1). Its laboratory measurement in human plasma involves extraction with perchloric acid, followed by extensive dialysis to eliminate excess acid before radioimmunoassay by various procedures (2-6). A commercial assay based upon the above work, marketed in kit form (Roche Diagnostics, Nutley, NJ 07110), is widely used for CEA quantitations. The method is tedious, in that each plasma extract must be dialyzed for 12-16 h vs de-ionized water, then dialyzed for 3 h vs buffer, with changes of water every 3 h. Moreover, the pH of the dialyzing buffer must be carefully controlled (7).
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Other techniques have been proposed involving the use of Sephadex G-50 columns (8) to eliminate the need for dialysis. A commercial column based on this technique (Isolab, Inc., Akron, OH 43321) did not work well in my hands: it was cumbersome for large analytical runs and gave poor results. A recently introduced method, in which heat treatment of serum or plasma is followed by solid-phase radioimmunoassay (9, 10) appears to have potential, but is not yet licensed for use in this country.
I used the conventional Roche assay, but substituted the use of polyacrylantide gel columns for dialysis to remove excess perchloric acid. The method compares favorably with dialysis, but is much faster and its greater cost is justified by the labor savings.
Materials and Methods

Columns:
Polyacrylamide gel columns (12 X 1.6 cm) were obtained from Clinetics Corp., Tustin, CA 92680.
Reagents: All reagents were the same as described in the Roch& procedure, except that the pH of the 10 mmol/L acetate buffer was 6.60 (±0.10). Assay Procedure To 0.5-mL plasma samples and controls add 2.0 mL of NaC1 solution (8.5 g/L) and mix. Add 2.5 mL of perchloric acid (1.2 mol/L) to each sample and control and mix; it is best to do this step one tube at a time. After centrifuging for 20 mm at 1000 X g, decant the supernates onto polyacrylamide columns pre-equilibrated with 10 mmol/L acetate buffer, pH 6.60 (±0.10), allow to drain, and add 6.0 mL of the acetate buffer to each column. Collect the eluate for use in the radioimmunoassay for CEA. Six milliliters of ethylenediaminetetraacetate-containing buffer (included in the kit) is used for the 10, 25, 50, and 100 sL CEA standards used in preparing the standard curve. Immediately recharge the column by adding at least 36 mL of the acetate buffer. Store the columns with 5 to 10 mL of the acetate buffer in them and with top and bottom closures in place.
Results
Perchloric acid elution profile. Label 40 test tubes (dimensions:
16 X 125mm). Extract one plasma sample as in the assay procedure. Select a column at random and allow it to drain. Add 1.0 mL of the perchloric acid reagent added to the polyacrylamide gel column. Over 97% of the activity elutes between the 5th and 8th milliliter of effluent. A secondary peak is seen (Figure 1 ) between the 18th and 26th milliliters of effluent, which probably represent#{225} CEA fragments and inorganic iodide. I analyzed 0.5-mL plasma samples, either without added CEA or 10, 25, or 50 L of Roche CEA standard (125 zg/L) added. Table 1 depicts the recoveries for both the dialysis and column methods.
Comparison
of column vs dialysis. 
Discussion
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The polyacrylamide gel column may bind some CEA-like substances, yielding slightly lower values than the dialysis method. Moreover, recovery studies show that with the column method about 20% less is accounted for than with the dialysis method. There was closer agreement at higher values, with equal recoveries for both methods. All results that exceeded the highest standard in the dialysis method also exceeded the highest standard in the column procedure. Many samples that dialysis indicated contained CEA in the 0.5 to 2.0 zg/L range gave undetectable results with the column, i.e., higher counts than the zero standard. The reasons for this are not known. The current cost of each assay on a column is about $0.75, based on 20 uses per column. The time saved in labor should enable a laboratory to justify use of the polyacrylamide column. Moreover, results are available to the clinician the same day that the sample is submitted to the laboratory.
